Search hospitals > Ohio > Perrysburg
Mercy Health Perrysburg Cancer Center
Claim this profilePerrysburg, Ohio 43551
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
104 reported clinical trials
1 medical researcher
Summary
Mercy Health Perrysburg Cancer Center is a medical facility located in Perrysburg, Ohio. This center is recognized for care of Cancer, Breast Cancer, Tumors, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Mercy Health Perrysburg Cancer Center is involved with conducting 104 clinical trials across 274 conditions. There are 1 research doctors associated with this hospital, such as Timothy D. Moore.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage III
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Clinical Trials running at Mercy Health Perrysburg Cancer Center
Lung Cancer
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Melanoma
Cutaneous Melanoma
Tumors
Small Cell Lung Cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Sotorasib
for Non-Small Cell Lung Cancer
This study is evaluating whether a drug called AMG 510 can help treat non-small cell lung cancer.
Recruiting2 awards Phase 219 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to standard treatment (image guided radiation therapy [IGRT] and chemotherapy followed by immunotherapy with durvalumab) versus standard treatment alone in treating patients with non-small cell lung cancer that cannot be treated by surgery (inoperable). SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. IGRT is a type of radiation that uses a computer to create picture of the tumor, to help guide the radiation beam during therapy, making it more accurate and causing less damage to healthy tissue. Standard chemotherapy used in this trial consists of combinations of the following drugs: cisplatin, carboplatin, paclitaxel, pemetrexed, and etoposide. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Paclitaxel is in a class of medications called antimicrotubule agents. It works by stopping the growth and spread of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by blocking the action of a certain substance in the body that may help tumor cells multiply. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill tumor cells. Immunotherapy with durvalumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Adding SBRT to the standard treatment of IGRT with chemotherapy and immunotherapy may be more effective at treating patients with inoperable non-small cell lung cancer than giving the standard treatment alone.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Health Perrysburg Cancer Center?
Mercy Health Perrysburg Cancer Center is a medical facility located in Perrysburg, Ohio. This center is recognized for care of Cancer, Breast Cancer, Tumors, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Mercy Health Perrysburg Cancer Center is involved with conducting 104 clinical trials across 274 conditions. There are 1 research doctors associated with this hospital, such as Timothy D. Moore.